Rights and permissions
About this article
Cite this article
Draft NICE guidance does not recommend mifamurtide. Pharmacoecon. Outcomes News 614, 9 (2010). https://doi.org/10.2165/00151234-201006140-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006140-00020